A Restorative Justice-Based Lung Cancer Screening Decision-Making Support Intervention Tailored for Black Individuals to Increase Lung Cancer Screening Among Black Community Members, RESTORE Trial

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age50-77
SponsorFred Hutchinson Cancer Center

About this trial

This clinical trial develops and studies whether a restorative justice-based lung cancer screening (LCS) decision-making support intervention tailored for Black individuals increases LCS among Black community members. Lung cancer remains the leading cause of cancer deaths among Black men and women. LCS with yearly low-dose chest computed tomography (CT) is recommended for people with current or recent tobacco use (within 15 years) who are aged 50-80 with at least a 20 pack-year smoking history. LCS lowers lung cancer death by 20%; however, data shows that LCS completion remains low among minority groups in the United States. The restorative justice-based LCS decision-making support intervention in this trial has been specifically tailored to meet the needs of Black individuals. It is designed to reduce racial unfairness by promoting trust, shared understanding, and empowerment in clinical decision making while addressing the social and historical circumstances of health inequalities. This may be an effective way to increase LCS among Black community members.

Eligibility criteria

Qualifiers

Identify as Black or African American

Between ages 50-77

Self-reported 20-pack year smoking history

Ongoing commercial tobacco use within the past 15 years

Disqualifiers

Has a documented chest CT within the past one year

Personal history of lung cancer or symptoms associated with lung cancer

Trial design

Treatments tested in this trial

  • Educational Intervention
  • Survey Administration
  • Interview
  • Electronic Health Record Review

Treatment groups

45 Participants
are divided into 1 treatment group

Sponsors and collaborators

Fred Hutchinson Cancer Center

Lead sponsor

AstraZeneca

Collaborator

Go2 Foundation

Collaborator